OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 12
Showing 12 citing articles:
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 21
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 21
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapy
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 21
Marc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
The Lancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 12, pp. 1129-1142
Closed Access | Times Cited: 21
Immunotherapy as a Therapeutic Strategy for Gastrointestinal Cancer—Current Treatment Options and Future Perspectives
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6664-6664
Open Access | Times Cited: 23
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6664-6664
Open Access | Times Cited: 23
Immunotherapeutic Potential of the Yellow Fever Virus Vaccine Strain 17D for Intratumoral Therapy in a Murine Model of Pancreatic Cancer
Alina S. Nazarenko, Yulia K. Biryukova, Kirill N. Trachuk, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 40-40
Open Access
Alina S. Nazarenko, Yulia K. Biryukova, Kirill N. Trachuk, et al.
Vaccines (2025) Vol. 13, Iss. 1, pp. 40-40
Open Access
Resistance Signatures to Oncolytic Vesiculoviruses in Pancreatic Ductal Adenocarcinoma
Chelsae R Watters, Oumar Barro, Musa Gabere, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200937-200937
Open Access
Chelsae R Watters, Oumar Barro, Musa Gabere, et al.
Deleted Journal (2025) Vol. 33, Iss. 1, pp. 200937-200937
Open Access
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Tarık Demır, Carolyn Moloney, Devalingam Mahalingam
Cancers (2025) Vol. 17, Iss. 5, pp. 715-715
Open Access
Lifestyle‐Related Risk Factors for Pancreatic Ductal Adenocarcinoma: A Longitudinal Analysis of 1,120,377 Individuals From the NHISS Cohort
Hyunseok Jee
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Hyunseok Jee
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access
Oncolytic adenovirus as pancreatic cancer-targeted therapy: Where do we go from here?
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 9
A‐Rum Yoon, JinWoo Hong, Bo‐Kyeong Jung, et al.
Cancer Letters (2023) Vol. 579, pp. 216456-216456
Open Access | Times Cited: 9
Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5533-5557
Closed Access | Times Cited: 2
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 8, pp. 5533-5557
Closed Access | Times Cited: 2
Current Clinical Landscape of Immunotherapeutic Approaches in Pancreatic Cancer Treatment
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi, et al.
(2023), pp. 327-380
Closed Access | Times Cited: 4
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi, et al.
(2023), pp. 327-380
Closed Access | Times Cited: 4
Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 501-520
Closed Access | Times Cited: 1
Nidhi N. Shah, Bhavarth P. Dave, Kashvi C. Shah, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 2, pp. 501-520
Closed Access | Times Cited: 1
KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis
Marc Otero-Mateo, Francesc Estrany, Sabrina Arcas-Márquez, et al.
Deleted Journal (2024) Vol. 33, Iss. 1, pp. 200928-200928
Open Access
Marc Otero-Mateo, Francesc Estrany, Sabrina Arcas-Márquez, et al.
Deleted Journal (2024) Vol. 33, Iss. 1, pp. 200928-200928
Open Access
